Clinical Trial Update: Mifepristone for Patients With Endometrial Cancer and LGESS [Phase 2]

View source ↗

Summary

A Phase 2 trial of mifepristone in patients with endometrial cancer and low-grade endometrial stromal sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Low Grade Endometrial Stromal Sarcoma

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED